NPI registry status
Active
2026 NPPES data Naturopath NPI 1053651760
Verify on CMS → Christopher Deszynski
Naturopath in Brattleboro, Vermont.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,762 in Naturopath, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
317
Medicare Part D claims · 30 beneficiaries · Naturopath avg: 127
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$184.76
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Christopher Deszynski filed 317 Medicare Part D claims in 2024 as a Naturopath in Brattleboro, Vermont, prescribing 89% generic.
- 317
- Part D claims, 2024
- 89%
- generic prescribing
- $184.76
- industry payments (Sunshine Act)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Christopher Deszynski
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1053651760), first enumerated 02/18/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 317 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Industry payment transparency
$184.76 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1053651760 · Naturopath
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1053651760
- ENUM-MID 2013
- TAX-MID 7K Naturopath
- RX-LIGHT 317
- BOOK-THIN 111 in Vermont
- PHOTO-ENUM Lindsay Wilkinson, N… · 2013
Christopher Deszynski's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
317 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Christopher Deszynski?
Quality data not reportedPrimary specialty
Naturopath
Medicare Part D claims
317 150% vs specialty avg
Specialty distribution in Vermont
How Naturopath compares to other specialties among Vermont providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Naturopath. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1053651760 |
|---|---|
| Specialty | Naturopath |
| Gender | Male |
| NPI Issued | 02/18/2013 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Christopher Deszynski. Source: openpaymentsdata.cms.gov.
Total received
$185
Largest payer
Eko Health, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Christopher Deszynski - brand share 11.0%
Naturopath average
11% brand-name claims vs 89% generic, on 317 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
317
Total Claims
$26K
Total Drug Cost
30
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 511.6
- Total Day Supply
- 13,816
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $21K
- Generic Drug Cost
- $5K
- Opioid Claims
- 40 (12.6% rate)
- Antibiotic Claims
- 23
Patient Demographics
- Average Patient Age
- 64.6 years
- Avg HCC Risk Score
- 0.77
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 13, 65-74: N/A, 75-84: N/A, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Christopher Deszynski prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clonazepam
Clonazepam
34 claims
- Pregabalin
Pregabalin
15 claims
- Nucynta Er 13
Nucynta Er
13 claims
- Gabapentin 11
Gabapentin
11 claims
- Hydrocodone-Acetam… 11
Hydrocodone-Acetaminophen
11 claims
- Levothyroxine Sodium 11
Levothyroxine Sodium
11 claims
- Metoprolol Succinate 11
Metoprolol Succinate
11 claims
| Drug | Claims |
|---|---|
| Clonazepam | 34 |
| Pregabalin | 15 |
| Nucynta Er Tapentadol Hcl | 13 |
| Gabapentin | 11 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 11 |
| Levothyroxine Sodium | 11 |
| Metoprolol Succinate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Naturopath Overview
How Christopher Deszynski fits within the Naturopath landscape nationally.
6,762
Naturopath Providers in US
53
States with Naturopath
127
Avg Claims per Provider
Christopher Deszynski's 317 claims are above the specialty average of 127.
Nationwide Naturopath peers with similar MIPS or enrollment year
Two federal-record peer sets for Deszynski, both outside Vermont so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Naturopath Providers in Vermont
Other clinicians with the same primary specialty enrolled in Vermont, drawn from the same CMS NPPES roster as Deszynski.
One of 111 Naturopath providers enrolled in Vermont, 5 are shown here.
Anna Abele
Guilford, VT
Thauna Abrin
ND
Hardwick, VT
Cory Ambrose-Finch
ND, MAT
Burlington, VT
Laila Ames
N.D.
Brattleboro, VT
Gabriel Archdeacon
N.D.
Montpelier, VT
Compare Naturopath nationally: see state-by-state distribution →
Frequently Asked Questions
What is Christopher Deszynski's specialty? ▼
Christopher Deszynski specializes in Naturopath and practices in Brattleboro, Vermont.
How much does Christopher Deszynski prescribe under Medicare Part D? ▼
In 2024, Christopher Deszynski wrote 317 Medicare Part D claims totaling $26K in drug costs for 30 beneficiaries.
Where is Christopher Deszynski located? ▼
Christopher Deszynski is located at 73 MAIN ST STE 4, Brattleboro, VT, 05301. Phone: (802) 579-1679.
What is Christopher Deszynski's NPI number? ▼
Christopher Deszynski's National Provider Identifier (NPI) is 1053651760, issued on 02/18/2013.
Does Christopher Deszynski prescribe more brand-name or generic drugs? ▼
Christopher Deszynski's prescribing is 11% brand-name and 89% generic drugs by claim count, with $21K in brand drug costs.
Does Christopher Deszynski prescribe opioids? ▼
Yes, Christopher Deszynski had 40 opioid claims in 2024 with an opioid prescribing rate of 12.6%.
How many Naturopath providers are there in the US? ▼
There are 6,762 Naturopath providers across 53 states in the US. The average Naturopath provider writes 127 Medicare Part D claims per year.
What drugs does Christopher Deszynski prescribe most often? ▼
Based on 2024 Medicare Part D data, Christopher Deszynski's most frequently prescribed drugs include Clonazepam, Pregabalin, Nucynta Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Christopher Deszynski accept Medicare? ▼
Christopher Deszynski appears in CMS Medicare data with 317 Part D claims and 30 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Christopher Deszynski's credentials? ▼
Christopher Deszynski's NPI is 1053651760. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.